Clinical Trials & Research

Clinical Trials

Clinical research plays a vital role in advancing the treatments available to our patients and improving their access to care through their healthcare team.

At APDerm, our clinical research efforts focus on enhancing dermatologists' understanding of the real-world application of approved medications. We also explore promising new therapies and evaluate emerging technologies. Through these initiatives, our patients gain access to investigational treatments and products that may not be otherwise available.

Research

At APDerm, we actively engage in research and our team of experts are always investigating new ways to diagnose conditions and deliver treatment. We are currently participating in registries for psoriasis and atopic dermatitis. We are also actively engaged in building out infrastructure to support Phase II-IV clinical research for difficult and impactful dermatologic diseases. These include: 

• Hidradenitis suppurativa
• Vitiligo
• Alopecia areata
• Atopic dermatitis
• Psoriasis  

Areas of Study

We are expanding our clinical research portfolio and will soon be recruiting patients for trials focused on:
Treatment-resistant atopic dermatitis

• Hidradenitis suppurativa
• Alopecia areata
• Chronic pruritus
• Vitiligo
• Acne
• Prurigo nodularis
• Psoriasis
• Additional dermatologic conditions as new trials begin

These studies may provide eligible patients with access to therapies not yet available outside of a research setting, while contributing to the future of medical dermatology.

Our Research Team

Medical Director of Clinical Trials
David Li, MD

Investigators:

Byron Ho, MD

Brooks Kimmis, MD

Eric Xu, MD

Deep Joshipura, MD

Our investigators work collaboratively to ensure each study is conducted with the highest standards of patient safety, clinical quality, and scientific integrity.